Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $205,485 - $277,864
2,407 New
2,407 $256,000
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $155,548 - $234,511
-1,328 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $24,659 - $45,834
195 Added 17.21%
1,328 $229,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $255,854 - $417,521
1,133 New
1,133 $288,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Visionary Wealth Advisors Portfolio

Follow Visionary Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.